Teckro Logo
Transforming Clinical Trials

By Study NeedBy Study Role

January 13, 2022

Speaking the Same Language. Dispelling Myths in Minority Communities About Clinical Trials - Van Johnson

      Photo of Van Johnson

      Van Johnson

      VP of Business Development at Benchmark Research


    With ethnic minorities representing as little as 2% of all clinical trial participants in the US, Van Johnson, VP of business development at Benchmark Research, talks about the pressing issues surrounding underserved communities. He advises on how to increase engagement by addressing fears and speaking the "right language" and shares his optimism for the future in closing the clinical trial gap.

    “The key to building trust is for the pharmaceutical companies, the CROs, and clinical research sites to understand and acknowledge inequities.”

    Listen on Apple Podcast

    Listen on Spotify

    Listen on Google Podcast